跳至主要内容
临床试验/NCT07506161
NCT07506161已完成不适用

Thermoablation Treatment of Malignant Thyroid Carcinomas

Premier G Med Cardio Kft1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2021年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27
试验地点
1

研究概览

简要总结

Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with cytologically confirmed papillary thyroid carcinoma with the longest diameter of less than or equal to 10 mms in T1aN0M0 clinical stage without metastases and without cytological signs of aggressivity AND
  • Patients objecting to both surgery and active surveillance

排除标准

  • History of or active disease: neck irradiation, stroke, CV disease, CNS vascular malformation, any malignant disease, immunocompromised state, recurrent laryngeal nerve paresis, organ failure
  • extrathyroidal extension of tumor (including capsular)
  • pregnancy
  • lesion less than 5 mm close to the danger zone
  • safety margin could not be obtained (min 2mm)
  • uncontrolled hyperthyroidism
  • uncontrolled hypothyroidism
  • primary hyperparathyroidism
  • calcitonin or serum calcium over the threshold on a repeat blood test

研究者

发起方
Premier G Med Cardio Kft
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Pál Ákos Deák

associate professor, PhD

Premier G Med Cardio Kft

研究点 (1)

Loading locations...

相似试验